副甲状腺ホルモンの世界市場レポート 2025年

副甲状腺ホルモン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で35億米ドルに成長します。予測期間の成長は、高齢者人口の増加、民間ヘルスケアセクターの拡大、新たな適応症、精密医療、骨の健康に対する意識の高まり、ヘルスケアアクセスの拡大などに起因すると考えられます。予測期間における主な動向としては、副甲状腺ホルモン検査の進歩、ドラッグデリバリーの進歩、併用療法、デジタルヘルス統合、持続可能性と環境に配慮した取り組みなどが挙げられます。

副甲状腺ホルモン市場は、骨粗鬆症有病率の上昇により成長が見込まれます。2021年1月、骨折リスクの上昇につながる骨量の減少を特徴とする骨粗鬆症は、主に閉経後の女性や高齢者を中心に約140万人のカナダ人が罹患しています。骨粗鬆症患者の骨折リスクを軽減するために、カルシウム濃度を調整する副甲状腺ホルモンが毎日皮下注射で投与されています。このような骨粗鬆症患者の急増は、副甲状腺ホルモン市場の拡大に寄与すると予想されます。

老年人口の増加が、今後の副甲状腺ホルモン市場の成長を牽引すると予想されます。老年人口とは、通常65歳以上の高齢者を指し、加齢に伴う健康課題に直面し、専門的なケアやサポートを必要とする可能性があります。この人口動態の変化は、平均寿命の延び、ヘルスケアの進歩、出生率の低下によるところが大きく、社会における高齢者の割合が増加しています。副甲状腺ホルモンは、カルシウム濃度と骨代謝を調整し、高齢者に多い骨粗鬆症や骨折などの症状を予防するのに役立つため、この層にとって重要な役割を果たしています。たとえば、米国の非営利団体である人口問題研究所は、2024年1月、65歳以上のアメリカ人の数が2022年の5,800万人から2050年には8,200万人になり、47％増加すると予測しています。さらに、この年齢層が総人口に占める割合は、同期間に17％から23％に増加すると予想されています。したがって、老人人口の増加が副甲状腺ホルモン市場の拡大を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界副甲状腺ホルモンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の副甲状腺ホルモン市場：成長率分析
• 世界の副甲状腺ホルモン市場の実績：規模と成長, 2019-2024
• 世界の副甲状腺ホルモン市場の予測：規模と成長, 2024-2029, 2034F
• 世界副甲状腺ホルモン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の副甲状腺ホルモン市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低カルシウム血症
• 副甲状腺機能低下症
• 世界の副甲状腺ホルモン市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組み換え副甲状腺ホルモン
• 副甲状腺ホルモン類似品
• 世界の副甲状腺ホルモン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界の副甲状腺ホルモン市場低カルシウム血症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 偽性副甲状腺機能低下症
• ビタミンD欠乏症
• 世界の副甲状腺ホルモン市場、副甲状腺機能低下症の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 術後副甲状腺機能低下症
• 特発性副甲状腺機能低下症

第7章 地域別・国別分析

• 世界の副甲状腺ホルモン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の副甲状腺ホルモン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副甲状腺ホルモン市場：競合情勢
• 副甲状腺ホルモン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Radius Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Shire plc Overview, Products and Services, Strategy and Financial Analysis
  • Ascendis Pharma Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Entera Bio Ltd.
• Extend Biosciences Inc.
• Gedeon Richter Plc.
• Abbott Laboratories
• Amgen Inc.
• Merck & Co. Inc.
• Novartis AG
• F. Hoffmann-La Roche AG
• Teva Pharmaceutical Industries Ltd.
• Alcon Laboratories Inc.
• Bayer Healthcare
• Becton Dickinson and Company
• Ethicon Inc.
• Genentech Inc.
• Medtronic Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 副甲状腺ホルモン市場2029：新たな機会を提供する国
• 副甲状腺ホルモン市場2029：新たな機会を提供するセグメント
• 副甲状腺ホルモン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Parathyroid hormone, produced by the parathyroid gland, plays a crucial role in the body's calcium storage and utilization. Elevated levels of this hormone can lead to high blood calcium levels, potentially indicating a medical condition. It's also referred to as PTH, parathyrin, or parathormone.

Within the realm of parathyroid hormone products, there are recombinant parathyroid hormone and parathyroid hormone analogs. Recombinant parathyroid hormone, resembling natural parathyroid hormone, is utilized in treating osteoporosis. These products cater to conditions like hypocalcemia and hypoparathyroidism and are used across various healthcare settings such as hospitals, clinics, and others.

The parathyroid hormone market research report is one of a series of new reports from The Business Research Company that provides parathyroid hormone market statistics, including parathyroid hormone industry global market size, regional shares, competitors with a parathyroid hormone market share, detailed parathyroid hormone market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid hormone industry. This parathyroid hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parathyroid hormone market size has grown steadily in recent years. It will grow from $2.35 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing awareness of parathyroid hormone-related disorders, growing demand for parathyroid hormone analogs, increased government funding for parathyroid hormone research, rising disposable incomes.

The parathyroid hormone market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing geriatric population, expansion of private healthcare sectors, emerging indications, precision medicine, growing awareness of bone health, expanding healthcare access. Major trends in the forecast period include advances in parathyroid hormone testing, advances in drug delivery, combination therapies, digital health integration, sustainability and green initiatives.

The market for parathyroid hormones anticipates growth due to rising osteoporosis prevalence. In January 2021, Osteoporosis, characterized by reduced bone mass leading to higher fracture risks, affects approximately 1.4 million Canadians, primarily postmenopausal women and the elderly. Parathyroid hormones, regulating calcium levels, are administered via daily subcutaneous injections to mitigate fracture risks in osteoporosis patients. This surge in osteoporosis cases is expected to contribute to the expansion of the parathyroid hormone market.

The growing geriatric population is expected to drive the growth of the parathyroid hormone market in the future. The geriatric population refers to older adults, typically aged 65 and older, who may face age-related health challenges and require specialized care and support. This demographic shift is largely due to increased life expectancy, advancements in healthcare, and declining birth rates, leading to a larger proportion of elderly individuals in society. Parathyroid hormone plays a crucial role for this demographic as it regulates calcium levels and bone metabolism, helping to prevent conditions such as osteoporosis and fractures, which are prevalent among older adults. For example, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Additionally, this age group's share of the total population is expected to grow from 17% to 23% during the same period. Therefore, the increasing geriatric population is driving the expansion of the parathyroid hormone market.

Major companies in the parathyroid hormone market are increasingly focused on developing biosimilars of parathyroid-based drugs, such as prodrugs of parathyroid hormone (PTH), to expand treatment options. A prodrug of parathyroid hormone is an inactive compound that converts into active PTH after administration, allowing for prolonged release and stable therapeutic outcomes in calcium regulation and bone health. For example, in August 2024, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, announced that the Food and Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma supports patients through its Ascendis Signature Access Program (A.S.A.P.), although users must regularly monitor their serum calcium levels to detect potential hypercalcemia or hypocalcemia.

Major companies in the parathyroid hormone market are concentrating on innovative solutions, such as prodrugs, to enhance drug performance. A prodrug is an inactive compound that is metabolically converted into an active drug within the body. For example, in August 2022, Ascendis Pharma A/S, a biopharmaceutical company based in Denmark, submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational therapy, TransCon PTH (palopegteriparatide), intended for treating adult patients with hypoparathyroidism. TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore physiological PTH levels over a 24-hour period. This is essential for managing hypoparathyroidism, a condition characterized by insufficient parathyroid hormone production, which results in low calcium levels and related health complications.

Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, announced its decision to acquire Shire Plc for $46 billion. The acquisition is expected to accelerate the delivery of medicines to patients around the world with an expanded scale and geographical footprint by Takeda Pharmaceutical Company. It also increases the levels of the parathyroid hormone, natpara. Shire Plc is a pharmaceutical company based in the United States that specializes in innovative and rare disease drugs.

Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

North America was the largest region in the parathyroid hormone market in 2024. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The parathyroid hormone market consists of sales of parathormone and calcitonin. Values in this market are ''factory gate values,'' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Hormone Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on parathyroid hormone market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid hormone ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The parathyroid hormone market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Hypocalcemia; Hypoparathyroidism
• 2) By Product Type: Recombinant Parathyroid Hormone; Parathyroid Hormone Analogues
• 3) By End-User: Hospitals; Clinics; Other End-Users
• Subsegments:
• 1) By Hypocalcemia: Pseudohypoparathyroidism; Vitamin D Deficiency
• 2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism; Idiopathic Hypoparathyroidism
• Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Radius Health Inc.; Ascendis Pharma; Entera Bio Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Parathyroid Hormone Market Characteristics

3. Parathyroid Hormone Market Trends And Strategies

4. Parathyroid Hormone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Parathyroid Hormone Growth Analysis And Strategic Analysis Framework

• 5.1. Global Parathyroid Hormone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Parathyroid Hormone Market Growth Rate Analysis
• 5.4. Global Parathyroid Hormone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Parathyroid Hormone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Parathyroid Hormone Total Addressable Market (TAM)

6. Parathyroid Hormone Market Segmentation

• 6.1. Global Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypocalcemia
• Hypoparathyroidism
• 6.2. Global Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Parathyroid Hormone
• Parathyroid Hormone Analogues
• 6.3. Global Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-Users
• 6.4. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypocalcemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pseudohypoparathyroidism
• Vitamin D Deficiency
• 6.5. Global Parathyroid Hormone Market, Sub-Segmentation Of Hypoparathyroidism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post-Surgical Hypoparathyroidism
• Idiopathic Hypoparathyroidism

7. Parathyroid Hormone Market Regional And Country Analysis

• 7.1. Global Parathyroid Hormone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Parathyroid Hormone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Parathyroid Hormone Market

• 8.1. Asia-Pacific Parathyroid Hormone Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Parathyroid Hormone Market

• 9.1. China Parathyroid Hormone Market Overview
• 9.2. China Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Parathyroid Hormone Market

• 10.1. India Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Parathyroid Hormone Market

• 11.1. Japan Parathyroid Hormone Market Overview
• 11.2. Japan Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Parathyroid Hormone Market

• 12.1. Australia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Parathyroid Hormone Market

• 13.1. Indonesia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Parathyroid Hormone Market

• 14.1. South Korea Parathyroid Hormone Market Overview
• 14.2. South Korea Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Parathyroid Hormone Market

• 15.1. Western Europe Parathyroid Hormone Market Overview
• 15.2. Western Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Parathyroid Hormone Market

• 16.1. UK Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Parathyroid Hormone Market

• 17.1. Germany Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Parathyroid Hormone Market

• 18.1. France Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Parathyroid Hormone Market

• 19.1. Italy Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Parathyroid Hormone Market

• 20.1. Spain Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Parathyroid Hormone Market

• 21.1. Eastern Europe Parathyroid Hormone Market Overview
• 21.2. Eastern Europe Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Parathyroid Hormone Market

• 22.1. Russia Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Parathyroid Hormone Market

• 23.1. North America Parathyroid Hormone Market Overview
• 23.2. North America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Parathyroid Hormone Market

• 24.1. USA Parathyroid Hormone Market Overview
• 24.2. USA Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Parathyroid Hormone Market

• 25.1. Canada Parathyroid Hormone Market Overview
• 25.2. Canada Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Parathyroid Hormone Market

• 26.1. South America Parathyroid Hormone Market Overview
• 26.2. South America Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Parathyroid Hormone Market

• 27.1. Brazil Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Parathyroid Hormone Market

• 28.1. Middle East Parathyroid Hormone Market Overview
• 28.2. Middle East Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Parathyroid Hormone Market

• 29.1. Africa Parathyroid Hormone Market Overview
• 29.2. Africa Parathyroid Hormone Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Parathyroid Hormone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Parathyroid Hormone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Parathyroid Hormone Market Competitive Landscape And Company Profiles

• 30.1. Parathyroid Hormone Market Competitive Landscape
• 30.2. Parathyroid Hormone Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Radius Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Shire plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ascendis Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Parathyroid Hormone Market Other Major And Innovative Companies

• 31.1. Entera Bio Ltd.
• 31.2. Extend Biosciences Inc.
• 31.3. Gedeon Richter Plc.
• 31.4. Abbott Laboratories
• 31.5. Amgen Inc.
• 31.6. Merck & Co. Inc.
• 31.7. Novartis AG
• 31.8. F. Hoffmann-La Roche AG
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Alcon Laboratories Inc.
• 31.11. Bayer Healthcare
• 31.12. Becton Dickinson and Company
• 31.13. Ethicon Inc.
• 31.14. Genentech Inc.
• 31.15. Medtronic Inc.

32. Global Parathyroid Hormone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Parathyroid Hormone Market

34. Recent Developments In The Parathyroid Hormone Market

35. Parathyroid Hormone Market High Potential Countries, Segments and Strategies

• 35.1 Parathyroid Hormone Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Parathyroid Hormone Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Parathyroid Hormone Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer